deepmirror is building the foundation model for drug design. AI for drug design is limited by sparse and fragmented data, but our AI-native infrastructure empowers chemistry teams to better harness their data to progress programs faster, with fewer dead ends. With each project, the data sets grow and the model improves, generating even greater outcomes. We are based in London and already trusted by 100+ organisations across the globe. For more information, visit http://deepmirror.ai
| Website | https://deepmirror.ai |
| Employees | 15 (14 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Drug Design Software, Molecular Modeling Software, Drug Development Software, Drug Discovery Platform, Cheminformatics Software, In Silico Drug Design, Life Science Software, Biotechnology Software, Pharmaceutical Software |
| Competitors | Microsoft, IBM, Google, NVIDIA, DataRobot, H2O.ai, PathAI, Biofourmis, Aidoc, Zegami +34 more (view full list) |
Looking for a particular DeepMirror employee's phone or email?
Max Jakobs is the Co-Founder and CEO of DeepMirror.
14 people are employed at DeepMirror.
DeepMirror is based in London, England.